TFEB and Alzheimer disease: On the other hand, TFEB can attenuate the pathogenesis of AD by facilitating the uptake and lysosomal degradation of Aβ in astrocytes (Xiao et al., 2014), which is consistent with our observations in ASA-treated astrocytes (Figure 6D).